Discover 210 paid clinical trials in Morgantown, West Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 210
Active & Responsive
EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry
for
RFA, Microwave Ablation, Pancreatic Lesion,
Location: Morgantown WV
Sponsor: West Virginia University
Sex: All
Age: 18+
Code: NCT07625189
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Morgantown WV, Fredericksburg VA, Hamilton,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
for
Kidney Disease
Location: Morgantown WV, Arlington VA, London, Cincinnati OH,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase3, Recruiting
Active & Responsive
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
for
Pancreatic Adenocarcinoma Non-resectable
Location: Morgantown WV, Ann Arbor MI
Sponsor: Continuity Biosciences, LLC
Sex: All
Age: 18+
Code: NCT07481383
Phase1, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Morgantown WV, Washington PA, Greensburg PA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder, Opioid Use Disorder, Moderate,
Location: Morgantown WV, Huntington WV, Greenville SC, Chicago IL,
Sponsor: T. John Winhusen, PhD
Sex: All
Age: 18+
Code: NCT06651177
Phase2, Recruiting
Active & Responsive
Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease
for
Degenerative Disc Disease
Location: Morgantown WV, Philadelphia PA, Little Rock AR,
Sponsor: CGBio Inc.
Sex: All
Age: 21 - 70+
Code: NCT07017634
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Cumberland MD, Westminster MD, Washington D.C. DC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
for
Hypoparathyroidism
Location: Morgantown WV
Sponsor: Ascendis Pharma A/S
Sex: Female
Age: 18 - 50
Code: NCT07264634
Recruiting
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
for
Atopic Dermatitis
Location: Morgantown WV, Rockville MD, Columbia MD, Glenn Dale MD,
Sponsor: Galderma R&D
Sex: All
Age: 12+
Code: NCT06988605
Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Morgantown WV, DuBois PA, Rockville MD, Allen Park MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06961214
Phase3, Recruiting
A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding
for
Hypoparathyroidism
Location: Morgantown WV
Sponsor: Ascendis Pharma A/S
Sex: Female
Age: 15 - 50
Code: NCT07345494
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine